Follow-The-Filings

Security

Nervgen Pharma C

COMMON STOCK

Equity holders as of 2026 Q1 (each manager’s latest book)

1 owner 1 new max 0.0% (Marshall Wace - Marshall ...)

owners 1
max % 0.0%
tracked value $755
qoq N 1

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% New 0.0% 200,359 $755 hist